Targeted therapy developed by Hanmi, ‘Olita Tab’ approved as 27th domestic new drug

A Hanmi-developed targeted therapy for lung cancer acquired approval as the 27^th domestic new drug.

The Ministry of Food and Drug Safety announced approval of the first domestically-developed targeted therapy for lung cancer, ‘Olita Tab 200mg(olmutinib)’ and ‘Olita Tab 400mg,’ on May 13.

Target therapy is a drug that inhibits proliferation and growth of cancer cells through disturbing signals...